drugset / Trial / NCT06716879
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of a Single Dose of Donzakimig in Healthy Chinese and Japanese Participants
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of the study is to investigate the safety, tolerability, and pharmacokinetic parameters of 2 dose strengths of donzakimig, each administered subcutaneously as a single dose, in healthy Chinese and Japanese study participants.
Timeline
- Start
- 2024-12-06
- Primary completion
- 2025-04-04
- Completion
- 2025-04-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donzakimig | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.